6 assets in High Grade Astrocytic Tumor

Therapeutic assets addressing High Grade Astrocytic Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pembrolizumab High Grade Astrocytic Tumor	Mayo Clinic	P2	CCC (53)
Efineptakin Alfa High Grade Astrocytic Tumor	Mayo Clinic	P2	CCC (49)
Icapamespib High Grade Astrocytic Tumor	Samus Therapeutics, Inc.	P1	CC (43)
Survaxm High Grade Astrocytic Tumor	Children's Oncology Group	P1	CC (43)
Sotigalimab High Grade Astrocytic Tumor	Pediatric Brain Tumor Consortium	P1	CC (42)